Elevated Platelet Count
Essential thrombocythemia with platelet count typically greater than 600,000/µL
Reactive thrombocytosis from:
iron deficiency anemia
acute blood loss
rebound from marrow suppression or immune thrombocytopenia
Platelet counts greater than 1,000,000/µL are worrisome for acute thrombotic events.
Elevated platelet count with poorly functioning platelets does not present an increased risk for thrombosis.
Commonly Encountered Situations
Reactive thrombocytosis from a variety of causes is far more common than essential thrombocythemia (a chronic myeloproliferative disorder).
Suggested Additional Lab Testing
Test that reveals any of the causes of reactive thrombocytosis previously noted are valuable.
Tests to confirm the presence of essential thrombocythemia include:
bone marrow biopsy to show an increase in the number of megakaryocytes
normal RBC mass to exclude polycythemia vera
platelet aggregation study showing a selective impaired aggregation response only to epinephrine suggests essential thrombocythemia
Copyright © 2017, 2013 Decision Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Importance of PrEP for People Involved in Criminal Justice Systems
- CDC Report on Recommendation Adherence in Uncomplicated Gonorrhea Treatment
- Increasing Incidence of Syphilis in People With HIV
- FDA: Possible Risk of Neural Tube Birth Defects With Certain Antiretroviral Agents
- MenACWY-TT Vaccine Can Be Effectively Coadministered With Routine Pediatric Immunizations
- Infections Complicating the Use of Monoclonal Antibodies for Malignancy
- Curbing Overuse of Blood Cultures in the Emergency Department
- How Important Is the Timing of Antibiotics for Surviving Sepsis?
- The 'Attitude Roots' Underlying Antivaccination Beliefs
- Why Treating Major Depressive Disorder Improves Outcomes in HIV
- AAP Recommends Shot Over Nasal Spray for 2018-2019 Flu Season
- Study Supports Development of a Vaccine for Recurrent Vulvovaginal Candidiasis
- Liver Stiffness Measurement as a Potential Screening Tool for Liver-Related Events in HCV
- Doptelet Approved for Chronic Liver Disease Patients With Thrombocytopenia
- Good Evidence That HPV Vaccines Protect Against Cervical Precancer